ReviewFrontiers in oncology2022

Anti-cancer immune responses to DNA damage response inhibitors: Molecular mechanisms and progress toward clinical translation.

Lindsey Carlsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.